What factors are involved in the evaluation of dysartria?

Dysartria is a disorder of speech disruption that can represent related symptoms. These possible symptoms, including respiratory or swallowing problems, are important factors in evaluation of dysarthria. The manifestation of basic symptoms, such as vocalization disorders, also provide key information in evaluation. Both causes and symptoms help to create a categorization system for evaluation of dysarthria. Since the nervous system damage often determines the basis for this condition, neurological testing should also be considered as a primary factor.

Several forms of damage to the nervous system can cause muscle damage that controls speech, leading to dysarthria. An individual may have a congenital congenital defect that damages the nerves. Other conditions arise during the critical development years of childhood, such as brain palsy. On the other hand, there are usually degenerative disorders and represent a progressive deterioration of the function. Traumatic injuries, infection or sudden body deficits such as mRTVice can also disrupt nerve functioning and cause different types of dysarthria.

The location of the nervous system damage will affect the presentation of symptoms and the degree of severity during the evaluation of dysarthria. In general, damage to motor neurons in the brain cortex can cause most abnormalities. For example, spastic dysarthria is diagnosed when these central nerve cells are disturbed. Symptoms include the following: tense voice; Inability to call long phrases; consonant mixes; And low, slow speech speed. Damage to lower motor nerve cells that combine muscles are characterized by flabby dysarthria, which usually leads to fewer symptoms.

motor nerve cell damage may also occur in brain or basal ganglia of the brain, which is manifested as ataxia dysarthria and hykokinetic or hyperkinetic dysarthria. Damage in both areas can create some of the VThe above symptoms or other symptoms such as the improper use of the vowel, unusual tones or extended pauses in speech. While individuals may suffer damage to one area, mixed dysarthrias that affect different areas of the brain and nervous system, may be more common in dysarthria. Depending on the origin and severity of the damage, individuals may experience occasional speech problems or may suffer from long -term chronic abnormalities of speech.

Since influenced areas of brain control more effects than speech, other related conditions may develop together with speech difficulties. For example, affected individuals have voice quality. This effect is largely caused by impaired breathing. Furthermore, symptoms such as a tense voice are often the result of a deterioration in the primary nerves that control swallowing. At the psychological level, depression due to speech difficulties can be other wrinkles in the evaluation.

testing procedures such as the evaluation of French dySartria, which focus on speech patterns, help doctors in evaluation of dysarthria. The physician collects a speech of speech from the patient and carefully examines what properties are present in the patient's speech. For example, a doctor could notice abnormalities in the vocalization of small sound units or patient phonemes. In addition, a physical examination of the mouth and face area will be performed and any aberrations - especially if the patient - will be recorded. Brain display tests and blood tests can help reveal the source of the problem.

Due to all of the above factors, doctors will use the assessment to determine what type of therapeutic approach will best suit the patient. The patient's individual reaction to these conditions may dictate whether it will need long -term treatment and how well the treatment will work. In cases where symptoms are less serious, strengthening muscles related to speech by back therapy can often make it easier to improve. If the symptoms are ubiquitous and the duckThe evolution is located in several areas of the nervous system, then the auxiliary speech devices may be a better choice for the treatment of dysarthria.